Metastatic Triple Negative Breast Cancer: Overcoming Challenges in Diagnosis Treatment and Management - Episode 2

Initial Treatment Options for Metastatic TNBC

October 17, 2023
Nour Abuhadra, MD

Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.

EP. 1: Background on Metastatic Triple Negative Breast Cancer
Now Viewing
EP. 2: Initial Treatment Options for Metastatic TNBC
EP. 3: Second-Line Therapy for Metastatic TNBC
EP. 4: ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC
EP. 5: Managing Adverse Events in Patients Receiving Later Line Systemic Therapy for Metastatic TNBC
EP. 6: Overcoming Barriers to Treatment Access and Reimbursement

Related Content:

Metastatic Triple Negative Breast Cancer: Overcoming Challenges in Diagnosis Treatment and ManagementCURE Connections Breast Cancer
Imlunestrant-Based Therapy May Improve Survival Without Progression in Advanced Breast Cancer
Local Recurrence Lowered With Immediate Surgery in Elderly Patients With Breast Cancer
Lynparza Continues to Benefit in BRCA1/2+, HER2- Breast Cancer